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association of genetic variants in Toll-like receptors (TLRs) and
the risk of non-HIV cryptococcal meningitis (CM) [1]. CM represents a
major cause of morbidity and mortality in HIV-infected patients, espe-
cially in sub-Saharan Africa. In recent years however, a growing number
of cases has beenwitnessed among CD4-competent individuals, most of
which without any obvious predisposing conditions. This suggests that
susceptibility to CM may be, to a large extent, driven by other host or
environmental risk factors. Despite the remarkable inﬂuence of host
genetics on antifungal immune responses, very few studies have
addressed the contribution of interindividual genetic variation to the
risk of CM, particularly in the absence of HIV infection. Genetic variants
in Fc receptors for IgG (FcγR) [2,3] and mannose-binding lectin (MBL)
[4] stand out as the most relevant examples correlated with increased
susceptibility to non-HIV CM, suggesting a pivotal role of the humoral
arm of innate immunity in anti-cryptococcal protection. However,
much less is known about the contribution of genetic variants in other
pattern recognition receptors to cryptococcal disease.
TLRs are pattern recognition receptors whose activation is responsi-
ble formechanisms involved in pathogen clearance, including the secre-
tion of cytokines and chemokines, and complex immunoregulatory
processes leading to the activation of adaptive immune responses.
These receptors have been vastly implicated in anti-cryptococcal immu-
nity [5], however the question remains as to which TLR-ligand interac-
tion is actually required for the recognition, phagocytosis, and
subsequent fungal killing. In this study, Jiang and colleagues provide
both genetic and immunological evidence highlighting the pivotal role
of TLR-dependentmechanismsof cryptococcal recognition and cytokine
production in deﬁning susceptibility to human CM in HIV-uninfected
individuals [1].
The ﬁndings reported herein support the exciting possibility for risk
stratiﬁcation and personalized medical interventions, particularly
among patients belonging to high-risk populations. However, their
immediate clinical translationmay be precluded by the limited number
of cases of infection that were enrolled and the relative lack of replica-
tion in the validation stages. More importantly, the associations
described may not be entirely generalizable since these may differDOI of original article: https://doi.org/10.1016/j.ebiom.2018.10.045.
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populations of various ethnic and geographic origins [6], and this may
explain the remarkably discrepant results obtained from previous asso-
ciation studies in cohorts of European and Asian ancestry. In addition,
common genetic variants account for differences in gene expression
among ethnic groups [7], and this may reﬂect important population-
speciﬁc effects on gene expression, including TLRs.
Although recent advances have contributed to an expanding num-
ber of genetic variants associated with the risk of fungal disease, little
is known about their functional consequences through effects on
deﬁned biological processes. The study by Jiang and colleagues corre-
lated the presence of genetic variants in TLRs with the levels of cyto-
kines detected in the cerebrospinal ﬂuid (CSF) of infected patients [1].
Besides providing functional validation to the association studies,
theseﬁndings uncover the potential usefulness of CSF cytokines as diag-
nostic biomarkers for CM, particularly if combined with fungal surro-
gate markers and integrating the genetic risk proﬁle of the patient [8].
Moreover, important mechanistic insights can also be drawn from
these analyses. In particular, high levels of interleukin (IL)-10 were
identiﬁed as an independent predictor for disease severity and this ﬁnd-
ing is reminiscent of recent studies performed in the context of invasive
pulmonary aspergillosis and that have identiﬁed IL-10 overexpression
as an important genetic mechanism of immune suppression contribut-
ing to fungal disease [9]. In support of this, the persistent IL-10 signaling
in dendritic cells has also been deemeddetrimental to cryptococcal lung
infection [10], illustrating the diversity of immune mechanisms that
may be deregulated by the presence of genetic variants in TLRs.
Several questions remain unanswered, the most relevant regarding
the inability to deﬁnitively conclude about the impaired molecular
and cellular processes that contribute to CM and that may reasonably
extend beyond cytokine production. In addition, this study warrants
further investigation on the likely interrelationships between different
genetic variants across several TLRs and their concerted effect toward
the development of fungal disease. A comprehensive appreciation of
the mechanisms through which genetic variation in TLRs contributes
to CMwill provide invaluable insights toward the identiﬁcation of mol-
ecules and signaling networks amenable to therapeutic targeting.
In conclusion, the ﬁndings presented in this study represent an im-
portant step toward uncovering a genetic susceptibility proﬁle to CM.
Recruitment of larger cohorts of patients from different ethnic back-
grounds, as well as functional studies dissecting the mechanisms ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
10 C. Cunha, A. Carvalho / EBioMedicine 37 (2018) 9–10associationwith infection, are ultimately required. Thiswill certainly at-
tract in the near future an increased focus toward the integration of ge-
netic markers into the clinical practice aimed at the stratiﬁcation of risk
and progression of fungal disease in general and CM in particular among
patients at-risk.
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